Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 5 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days
Sichuan University is managing 8 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are spread across 7 distinct examiners, which suggests a high degree of variety in the individual perspectives reviewing the university's applications. With 8 pending office actions and 7 distinct examiners, only a small portion of the portfolio is being handled by the same individual, requiring a flexible approach to prosecution across the different cases.
The university's current work involves 6 distinct art units, indicating that the active matters cover a broad range of technical sub-specialties within the biotechnology field. The busiest examiner, MORGAN, BAILEY MICHELLE, is currently assigned 2 busiest examiner pending office actions. This means that while most of the 7 distinct examiners are handling single cases, this specific examiner is managing a larger share of the university's workload. The presence of 6 distinct art units further underscores the complexity of the university's patent landscape, as the prosecution must align with the specific standards of multiple examination groups.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §103 only | 3 (50%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MORGAN, BAILEY MICHELLE | 2 | 56.3% | +58.3% |
| SITTNER, MICHAEL J | 1 | 10.9% | +14.9% |
| ABDEL LATIF, MAHMOUD MOTAZ | 1 | 75.0% | +0.0% |
| WELLES, COLMAN THOMAS | 1 | 29.2% | +64.2% |
| WILSON, MICHAEL C | 1 | 41.5% | +17.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18927523 | MODELING METHOD AND SYSTEM FOR CARBON EMISSIONS IN LEATHER MANUFACTURING PROCESS | SITTNER, MICHAEL J | — |
| 18346290 | NATURAL-POLYPHENOLS-BASED MULTI-STAGE POROUS HYDROGEL SUSTAINED RELEASE DRUG DELIVERY SYSTEM AND ITS PREPARATION METHOD | WELLES, COLMAN THOMAS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17637028 | APPLICATION OF PSEUDOMONAS AERUGINOSA VACCINE IN RESPIRATORY DISEASE | MORGAN, BAILEY MICHELLE | 92d overdue |
| 17637057 | APPLICATION OF PSEUDOMONAS AERUGINOSA VACCINE IN TREATING INFECTION ASSOCIATED WITH BURN OR SCALD INJURY | MORGAN, BAILEY MICHELLE | 38d overdue |
| 17915548 | AAV CAPSIDS VARIANTS AND USES THEREOF | WILSON, MICHAEL C | 8d overdue |
| 18927523 | MODELING METHOD AND SYSTEM FOR CARBON EMISSIONS IN LEATHER MANUFACTURING PROCESS | SITTNER, MICHAEL J | — |
| 18346290 | NATURAL-POLYPHENOLS-BASED MULTI-STAGE POROUS HYDROGEL SUSTAINED RELEASE DRUG DELIVERY SYSTEM AND ITS PREPARATION METHOD | WELLES, COLMAN THOMAS | — |
| Art Unit | Apps |
|---|---|
| 1645 | 2 |
| 3621 | 1 |
| 1773 | 1 |
| 1612 | 1 |
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18927523 | MODELING METHOD AND SYSTEM FOR CARBON EMISSIONS IN LEATHER MANUFACTURING PROCESS | SITTNER, MICHAEL J | 3621 | §101§103§112 | Non-Final OA | — | Pending | Oct 25, 2024 |
| 18432193 | METHOD FOR IMPROVING BIOLOGICAL NITROGEN REMOVAL EFFECT OF LOW-TEMPERATURE SEWAGE | ABDEL LATIF, MAHMOUD MOTAZ | 1773 | §103 | Final Rejection | — | Pending | Feb 05, 2024 |
| 18346290 | NATURAL-POLYPHENOLS-BASED MULTI-STAGE POROUS HYDROGEL SUSTAINED RELEASE DRUG DELIVERY SYSTEM AND ITS PREPARATION METHOD | WELLES, COLMAN THOMAS | 1612 | §103§112Other | Final Rejection | — | Pending | Jul 03, 2023 |
| 17915548 | AAV CAPSIDS VARIANTS AND USES THEREOF | WILSON, MICHAEL C | 1638 | §103 | Non-Final OA | 8d overdue | Pending | Sep 29, 2022 |
| 17637057 | APPLICATION OF PSEUDOMONAS AERUGINOSA VACCINE IN TREATING INFECTION ASSOCIATED WITH BURN OR SCALD INJURY | MORGAN, BAILEY MICHELLE | 1645 | §103 | Non-Final OA | 38d overdue | Pending | Aug 10, 2022 |
| 17637028 | APPLICATION OF PSEUDOMONAS AERUGINOSA VACCINE IN RESPIRATORY DISEASE | MORGAN, BAILEY MICHELLE | 1645 | §112DP | Final Rejection | 92d overdue | Pending | Jul 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial